Clinical Trial Update: Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial comparing blinatumomab to standard chemotherapy in high-risk first-relapse B-precursor acute lymphoblastic leukemia has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Amgen | Conditions: Leukemia, Acute Lymphoblastic | Phase 3 | Status: COMPLETED | Results posted: 2020-07-13